• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

12
1

CATEGORIES

  • 9
  • 6
  • 2
  • 1

PRICE

0
5
7
15

PUBLISHED

0
0
3
15

PRODUCT TYPE

15

Search "Emerging Opportunities in Biosimilar and Biobetter Drugs Markets" returned 15 results.

PRODUCT TITLE

Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings

GBI Research, the leading business intelligence provider, has released its latest research on, “Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk...

July 2012
FROM
Biosimilars: Current Situation & Future Prospects, Worldwide Biosimilars: Current Situation & Future Prospects, Worldwide - Product Thumbnail Image

Biosimilars: Current Situation & Future Prospects, Worldwide

The engine of the biosimilar sector is the same as with small molecule drugs, patent expiry On this basis, prospects for biosimilars look good, with the vast majority of leading originator brands in...

March 2012
Biosimilars and Biobetters: Positioning for a New Market 2009 Biosimilars and Biobetters: Positioning for a New Market 2009 - Product Thumbnail Image

Biosimilars and Biobetters: Positioning for a New Market 2009

As regulatory frameworks for biosimilars development begin to take shape worldwide, there are growing opportunities for generics companies to enter the biologics market, a segment which is uniquely...

July 2009
Biosimilar Drugs in Europe: Threat or Opportunity to Innovation? Biosimilar Drugs in Europe: Threat or Opportunity to Innovation? - Product Thumbnail Image

Biosimilar Drugs in Europe: Threat or Opportunity to Innovation?

Between now and 2019, a vast range of blockbuster drugs will go off patent, opening the floodgates in the EU to the biosimilars market Already established there since 2006, biosimilars are set to be...

November 2011
FROM
Biosimilars and Biobetters: Positioning for a New Market Biosimilars and Biobetters: Positioning for a New Market - Product Thumbnail Image

Biosimilars and Biobetters: Positioning for a New Market

As regulatory frameworks for biosimilars development begin to take shape worldwide, there are growing opportunities for generics companies to enter the biologics market, a segment which is uniquely...

July 2009

Biologics and Biosimilars World Markets

Biologics are complex molecules manufactured through cell culture recombinant DNA technology Biologics additionally comprise recombinant insulin, growth hormone and monoclonal antibodies for treating...

August 2013
FROM
Biosimilar Opportunities in an Evolving Market Biosimilar Opportunities in an Evolving Market - Product Thumbnail Image

Biosimilar Opportunities in an Evolving Market

The long awaited promise of biosimilars takes another step to fulfilment with the first approval in Europe of high-value second generation products But what products can be expected to follow, who is...

August 2013
FROM
The Global Active Pharmaceutical Ingredients (API) Market: Evaluating Challenges, Opportunities, Innovations and the Market Environment The Global Active Pharmaceutical Ingredients (API) Market: Evaluating Challenges, Opportunities, Innovations and the Market Environment - Product Thumbnail Image

The Global Active Pharmaceutical Ingredients (API) Market: Evaluating Challenges, Opportunities, Innovations and the Market Environment

Active pharmaceutical ingredients (APIs), also known as ‘bulk drug substances’, are defined by the US Food and Drugs Administration (FDA) as ‘any substance or mixture of substances intended to be used...

February 2010
FROM

Growth Strategies for Supergenerics Organizations - Opportunities in Addressing Unmet Medical Needs and Providing Cost-Effective Solutions for Product Development in Emerging Markets

GBI Research, a leading business intelligence provider, has released its latest research “Growth Strategies for Supergenerics Organizations - Opportunities in Addressing Unmet Medical Needs and Providing...

April 2012
FROM

Fc Protein and Glycoengineered Antibodies Market, 2013 - 2023

Engineered antibodies are antibody based therapeutics, which are gaining increasing attention from both large and small pharmaceutical companies Developed through introduction of modifications in monoclonal...

September 2013
FROM
Generics/Biosimilars Collection Generics/Biosimilars Collection - Product Thumbnail Image

Generics/Biosimilars Collection

Dossier Report Collections The authors are pleased to showcase Report Collections, focused on areas of critical importance to Pharma's success, present and future These Collections deliver expert views,...

November 2013
FROM
Biosimilars Biosimilars - Product Thumbnail Image

Biosimilars

In an environment where resources are scarce and patents are fast expiring, effective product planning is paramount to ensuring the success of your organisation Biologic drugs - noted as some of the...

March 2010
FROM
Global Biotechnology Market Global Biotechnology Market - Product Thumbnail Image

Global Biotechnology Market

Biotechnology has become the foundation on which the pharmaceutical industry and many others are progressing on. The biotech revolution has surpassed the IT revolution as well and has become the new...

October 2012
FROM

Biosimilars Market by Product & Application - Global Forecast to 2018

'Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides (Glucagon, Calcitonin)] & Application...

November 2013
FROM
The New Trends of Global Biomanufacturing Outsourcing The New Trends of Global Biomanufacturing Outsourcing - Product Thumbnail Image

The New Trends of Global Biomanufacturing Outsourcing

The fast growth of the global bio-pharmaceutical market has prompted all global major pharmaceutical companies to increase their R&D investment in biologics The increasing availability of funding opportunities...

July 2014
FROM
Loading Indicator